Ca 19.9 (G.I. Tract)

$ 380.00

Description

Ca 19.9 (G.I. Tract)
Sample Type:Serum

Tests Included:

Cancer Antigen 19-9 (CA 19-9) measurement

Sample Required:

Blood sample

Test Time:

Results are typically available within a few days.

Test Range Values:

Normal levels are usually below 37 units per milliliter (U/mL). Elevated levels might indicate certain gastrointestinal cancers or other conditions.

What is the test?

The CA 19-9 test measures the level of Cancer Antigen 19-9 in the blood, which can be elevated in some cases of gastrointestinal cancers, especially pancreatic cancer.

Test Procedure:

A blood sample is drawn from a vein, and the concentration of CA 19-9 is measured in the laboratory.

When to take the test:

The test is recommended for monitoring certain gastrointestinal cancers, assessing response to treatment, or detecting disease recurrence.

Who should take the test:

Patients with gastrointestinal cancers, especially pancreatic cancer, undergoing treatment, or being monitored might require this test. It’s usually ordered by oncologists or gastroenterologists.

Precautions for exceptional cases (pregnancy, etc.):

Pregnancy can cause elevated CA 19-9 levels. Pregnant individuals should inform their healthcare provider.

 

Frequently Asked Questions (FAQs) for Ca 19-9 (Gastrointestinal Tract) Test:

Q1: Can CA 19-9 levels be elevated in conditions other than gastrointestinal cancers?

A: Yes, elevated CA 19-9 levels can also occur in conditions like biliary obstruction, pancreatitis, or cirrhosis, not necessarily indicating cancer.

Q2: Is CA 19-9 used as a screening test for pancreatic cancer?

A: CA 19-9 isn’t recommended as a screening test due to its limitations in detecting early-stage pancreatic cancer.

Q3: Can lifestyle changes impact CA 19-9 levels?

A: Lifestyle changes typically do not significantly affect CA 19-9 levels. Regular check-ups and healthy practices contribute to overall health.

Q4: How frequently should CA 19-9 levels be monitored in cancer patients?

A: The frequency of testing is determined by the healthcare provider based on individual factors, treatment response, and disease status.

Q5: Can CA 19-9 levels help predict prognosis in cancer?

A: Elevated CA 19-9 levels might indicate disease progression or recurrence, but they aren’t used alone to predict prognosis.

*Please note that specific testing protocols and guidelines may vary based on the latest recommendations from health authorities and regulatory agencies. It is essential to consult healthcare professionals and follow local testing guidelines for accurate and appropriate testing.

Cart
Your cart is currently empty.